Exopharm

Exopharm is a clinical-stage biopharmaceutical company at the forefront of developing transformative exosome-based therapeutics. The company's mission is to become a global leader in exosome-based therapies. Exopharm possesses two exclusive proprietary technologies that enable advanced customization of exosomes: LOAD technology, which enhances the loading of nucleic drugs into exosomes, and EVPS technology, which allows for the targeted delivery of exosomes to selected cell types. By utilizing variants and combinations of LOAD and EVPS, Exopharm empowers its biopharmaceutical partners to improve the delivery of their drug candidates and to design and test new exosome-based therapeutics aimed at treating a wide range of medical conditions, including neurological disorders, infectious diseases, cancer, and fibrosis.